A detailed history of Sage Mountain Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sage Mountain Advisors LLC holds 5,060 shares of LLY stock, worth $3.88 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
5,060
Previous 4,862 4.07%
Holding current value
$3.88 Million
Previous $4.4 Million 1.84%
% of portfolio
0.39%
Previous 0.41%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$772.14 - $960.02 $152,883 - $190,083
198 Added 4.07%
5,060 $4.48 Million
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $447,969 - $561,786
618 Added 14.56%
4,862 $4.4 Million
Q1 2024

Apr 23, 2024

SELL
$592.2 - $792.28 $115,479 - $154,494
-195 Reduced 4.39%
4,244 $3.3 Million
Q4 2023

Feb 01, 2024

BUY
$525.19 - $619.13 $141,801 - $167,165
270 Added 6.48%
4,439 $2.59 Million
Q3 2023

Oct 25, 2023

BUY
$434.7 - $599.3 $89,548 - $123,455
206 Added 5.2%
4,169 $2.24 Million
Q2 2023

Jul 24, 2023

SELL
$350.74 - $468.98 $32,969 - $44,084
-94 Reduced 2.32%
3,963 $1.86 Million
Q1 2023

Apr 25, 2023

BUY
$310.63 - $364.82 $743,337 - $873,014
2,393 Added 143.81%
4,057 $1.39 Million
Q4 2022

Feb 01, 2023

BUY
$321.55 - $374.67 $17,363 - $20,232
54 Added 3.35%
1,664 $608,000
Q3 2022

Oct 31, 2022

SELL
$296.48 - $337.87 $30,833 - $35,138
-104 Reduced 6.07%
1,610 $521,000
Q2 2022

Aug 01, 2022

SELL
$278.73 - $327.27 $11,427 - $13,418
-41 Reduced 2.34%
1,714 $556,000
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $3,755 - $4,666
-16 Reduced 0.9%
1,755 $503,000
Q4 2021

Feb 02, 2022

BUY
$224.85 - $279.04 $23,159 - $28,741
103 Added 6.18%
1,771 $489,000
Q3 2021

Nov 01, 2021

BUY
$221.6 - $272.71 $93,736 - $115,356
423 Added 33.98%
1,668 $385,000
Q2 2021

Jul 22, 2021

BUY
$180.55 - $233.54 $27,443 - $35,498
152 Added 13.91%
1,245 $286,000
Q1 2021

May 10, 2021

BUY
$164.32 - $212.72 $179,601 - $232,502
1,093 New
1,093 $204,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sage Mountain Advisors LLC Portfolio

Follow Sage Mountain Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Mountain Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Mountain Advisors LLC with notifications on news.